← Eichor
Condition: Immunotoxicity Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Immunotoxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy
Phase 1/Phase 2 · 6 location(s) · CytoAgents, Inc. · NCT05905328Autoimmunity After Checkpoint Blockade
Phase N/A · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT04119713Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Phase N/A · 2 location(s) · University Hospital, Montpellier · NCT06627595
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.